Gene Expression Analysis of Immune-Mediated Arrest of Tumorigenesis in a Transgenic Mouse Model of HER-2/neu-Positive Basal-Like Mammary Carcinoma
Open Access
- 1 April 2005
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 166 (4), 1205-1216
- https://doi.org/10.1016/s0002-9440(10)62339-5
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Immunoprevention of HER-2/ neu Transgenic Mammary Carcinoma through an Interleukin 12-Engineered Allogeneic Cell VaccineCancer Research, 2004
- Stem cells and breast cancer: A field in transitNature Reviews Cancer, 2003
- Breast cancer classification and prognosis based on gene expression profiles from a population-based studyProceedings of the National Academy of Sciences, 2003
- Cancer vaccines: between the idea and the realityNature Reviews Immunology, 2003
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccinationGene Therapy, 2001
- p185neu protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinomaInternational Journal of Cancer, 2000
- Definition of the Tumor Protein D52 (TPD52) Gene Family through Cloning ofD52Homologues in Human (hD53) and Mouse (mD52)Genomics, 1996